Jessie Stuckey, APRN
Psychiatric/Mental Health · Little Rock, ARNPI 1114571072
Payments from drug & device makers
Across 121 payments — averaging $22.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuronetics, Inc.$583
- Otsuka America Pharmaceutical, Inc.$374
- Axsome Therapeutics, Inc.$299
- AbbVie$290
- Johnson & Johnson$253
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$249
- plus $665 from 8 others
What the payments were for
- Food & beverage$2,712100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuronetics, Inc. | 6 | $583 |
| Otsuka America Pharmaceutical, Inc. | 19 | $374 |
| Axsome Therapeutics, Inc. | 13 | $299 |
| AbbVie | 24 | $290 |
| Johnson & Johnson | 11 | $253 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $249 |
| Alkermes, Inc. | 8 | $158 |
| Lundbeck LLC | 8 | $158 |
| Neurocrine Biosciences, Inc. | 7 | $123 |
| Teva Pharmaceuticals USA, Inc. | 4 | $66 |
| Corium, LLC | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $44 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,712 in reported general payments places this provider in the 80th percentile of 359 psychiatric/mental health providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 100 | $1,942 |
| Aripiprazole | 50 | $1,608 |
| Lamotrigine | 73 | $913 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 28 | $715 |
| Buspirone Hcl | 52 | $681 |
| Bupropion XlBupropion Hcl | 47 | $654 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 32 | $598 |
| Quetiapine Fumarate | 26 | $413 |
| Escitalopram Oxalate | 68 | $388 |
| Prazosin Hcl | 26 | $359 |
| Mirtazapine | 17 | $293 |
| Propranolol Hcl | 18 | $168 |
| Fluoxetine Hcl | 33 | $156 |
| Zolpidem Tartrate | 25 | $148 |
| Citalopram HbrCitalopram Hydrobromide | 24 | $122 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Little Rock
- Cara MeckfesselLittle Rock$8K
- Stacey HughesLittle Rock$7K
- Michelle HeadLittle Rock$6K
- Sara JonesLittle Rock$6K
- Alicia BarosLittle Rock$6K
- Adrianne FunmakerLittle Rock$5K
- Chloe WardLittle Rock$4K
- Ashley TaylorLittle Rock$4K
- Kizzie HoustonLittle Rock$3K
- Jennifer RawlsLittle Rock$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.